Mountain Valley MD Announces Stock Option Grant
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB:MVMDF) (FRA: 20MP), an early-stage biotech business centered around the implementation, licensing and reselling of key technologies and formulations, today announced the grant of stock options pursuant to its existing stock option plan (the “Stock Option Plan”).
Related news for (MVMDF)
- Mountain Valley MD Provides Business Update, Advances Commercialization
- Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program
- Mountain Valley MD Provides Business Update, Appoints New CFO
- Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024